Virtus ETF Advisers LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 149 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$86,000
-43.4%
131,413
-5.6%
0.04%
-33.3%
Q4 2021$152,000
+16.0%
139,201
+93.2%
0.06%
-1.7%
Q3 2021$131,000
-34.5%
72,060
-5.0%
0.06%
-29.3%
Q2 2021$200,000
-42.9%
75,826
-22.0%
0.08%
-44.6%
Q1 2021$350,000
+45.2%
97,179
+1.8%
0.15%
+48.0%
Q4 2020$241,000
-3.6%
95,473
-3.7%
0.10%
-23.7%
Q3 2020$250,000
-32.2%
99,108
-12.0%
0.13%
-25.1%
Q2 2020$369,000
+106.1%
112,619
+54.4%
0.18%
+136.5%
Q1 2020$179,000
-54.6%
72,930
-12.7%
0.07%
+15.6%
Q4 2019$394,000
+90.3%
83,568
+72.6%
0.06%
+52.4%
Q3 2019$207,000
-30.5%
48,404
-5.3%
0.04%
-33.3%
Q2 2019$298,000
-16.1%
51,100
-44.5%
0.06%
-91.7%
Q1 2019$355,000
+84.9%
92,148
-10.4%
0.76%
+2187.9%
Q4 2018$192,000
-45.9%
102,888
-7.2%
0.03%
-10.8%
Q3 2018$355,000
-38.2%
110,837
-41.7%
0.04%
-92.7%
Q2 2018$574,000
-17.4%
190,062
+7.1%
0.51%
-15.9%
Q1 2018$695,000
+105.6%
177,399
+117.1%
0.60%
+42.2%
Q4 2017$338,000
-6.6%
81,724
+38.5%
0.42%
+765.3%
Q3 2017$362,000
+8.7%
59,009
+10.1%
0.05%
-2.0%
Q2 2017$333,000
+17.7%
53,612
+20.1%
0.05%0.0%
Q1 2017$283,000
+31.0%
44,638
+10.6%
0.05%
-23.1%
Q4 2016$216,000
-4.4%
40,359
+0.5%
0.06%
-40.4%
Q3 2016$226,000
+2.3%
40,1750.0%0.11%
-33.5%
Q2 2016$221,000
+2.8%
40,175
+38.4%
0.16%
-44.6%
Q1 2016$215,00029,0200.30%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders